Learning Objectives:
By the end of this session, participants will be able to:

• Identify patients and populations at risk for Dry Eye Disease (DED) 
• Describe the underlying mechanisms contributing to DED, including the role of the inflammatory cascade 
• Apply the DEWS IITM definitions and classifications of DED 
• Diagnose DED and perform an initial work-up to guide subsequent therapy 
• Describe how new available treatments fit into the therapeutic arsenal for DED and choose the appropriate therapeutic options for patients

Agenda:
06:30 PM ADT: Registration
07:30 PM ADT: Presentation
08:55 PM ADT: Conclusion and Evaluation